levamisole has been researched along with ranitidine in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Tassi, GC; Valcurone, G | 1 |
| Wani, MK; Woodson, GE | 1 |
| Gocmen, H; Kasap, SC; Mecitoglu, Z; Onat, K; Temizel, EM; Ulgen, M | 1 |
1 review(s) available for levamisole and ranitidine
| Article | Year |
|---|---|
Immunomodulators and allergy.
Topics: Acetylmuramyl-Alanyl-Isoglutamine; Animals; Annexins; Antibody Specificity; Calcium Channel Blockers; Calmodulin; Chemotaxis, Leukocyte; Cimetidine; Circadian Rhythm; Corynebacterium; Cromolyn Sodium; Drug Administration Schedule; Epitopes; Glycoproteins; Histamine; HLA Antigens; Humans; Hypersensitivity; Immune System; Immunoglobulin E; Immunoglobulin Fc Fragments; Immunotherapy; Interferons; Killer Cells, Natural; Leukotriene B4; Levamisole; Macrophages; Prostaglandins; Ranitidine; Receptors, Complement; Receptors, Complement 3b; Steroids; T-Lymphocytes | 1985 |
1 trial(s) available for levamisole and ranitidine
| Article | Year |
|---|---|
Effects of levamisole and ranitidine on antibody-forming responses induced by killed Mycoplasma vaccine antigens in Saanen goats.
Topics: Adjuvants, Immunologic; Animals; Antibodies, Bacterial; Antinematodal Agents; Female; Goat Diseases; Goats; Histamine H2 Antagonists; Levamisole; Mycoplasma agalactiae; Mycoplasma Infections; Ranitidine; Vaccination; Vaccines, Inactivated | 2012 |
5 other study(ies) available for levamisole and ranitidine
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Laryngeal contact granuloma.
Topics: Adult; Aged; Anti-Dyskinesia Agents; Botulinum Toxins; Female; Granuloma; Histamine H2 Antagonists; Humans; Laryngeal Neoplasms; Levamisole; Male; Middle Aged; Omeprazole; Prospective Studies; Proton Pump Inhibitors; Ranitidine; Treatment Outcome | 1999 |